SLC2A1 and Alzheimer disease: The increase of HIF-1α in 24- and 56-week-old AD mice administered with SLAB51 corroborates previously published data showing that chronic treatment with the same probiotic formulation ameliorated glucose uptake in 3xTg-AD mice by increasing the brain expression of GLUT1 and GLUT3 [7].